Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28423365 | 1.00 | ATM (0.43) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL37109 | 0.89 | ATM (0.47) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL14777782 | 0.87 | ATM (0.57) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL110602 | 0.87 | ATM (0.57) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL16681370 | 0.87 | ATM (0.57) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL1132928 | 0.84 | ATM (0.46) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL728878 | 0.84 | ATM (0.42) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL12445250 | 0.84 | ATM (0.42) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL25317040 | 0.83 | HCAR2 (0.45) | ATMHCAR2MAPTRAB9ANPSR1 | |
| SCHEMBL25317335 | 0.83 | HCAR2 (0.45) | ATMHCAR2MAPTRAB9ANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3310792-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3310793-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-06-09 | — | — | EP | claimed |
| US-10273254-B2 | Process for preparing an acryloyloxysilane | DOW CORNING CORPORATION (US) | 2019-04-30 | — | — | US | claimed |
| US-10246473-B2 | Process for preparing an acryloyloxysilane | DOW CORNING CORPORATION (US) | 2019-04-02 | — | — | US | claimed |
| US-20180155371-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORPORATION | 2018-06-07 | — | — | US | claimed |
| US-20180134734-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORPORATION | 2018-05-17 | — | — | US | claimed |
| EP-3310793-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | Dow Corning Corporation (US) | 2018-04-25 | — | — | EP | claimed |
| EP-3310792-A1 | PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE | Dow Corning Corporation (US) | 2018-04-25 | — | — | EP | claimed |
| WO-2016205642-A1 | PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE | DOW CORNING CORPORATION (US) | 2016-12-22 | — | — | WO | claimed |
| WO-2016205648-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW CORNING CORPORATION (US) | 2016-12-22 | — | — | WO | claimed |
| EP-3310792-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-07-21 | — | — | EP | disclosed |
| EP-3310793-B1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW SILICONES CORP (US) | 2021-06-09 | — | — | EP | disclosed |
| US-10273254-B2 | Process for preparing an acryloyloxysilane | DOW CORNING CORPORATION (US) | 2019-04-30 | — | — | US | disclosed |
| US-10246473-B2 | Process for preparing an acryloyloxysilane | DOW CORNING CORPORATION (US) | 2019-04-02 | — | — | US | disclosed |
| EP-2785726-B1 | ESTER-FUNCTIONAL SILANES AND THE PREPARATION AND USE THEREOF; AND USE OF IMINIUM COMPOUNDS AS PHASE TRANSFER CATALYSTS | DOW SILICONES CORP (US) | 2018-08-01 | — | — | EP | disclosed |
| EP-3310793-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | Dow Corning Corporation (US) | 2018-04-25 | — | — | EP | disclosed |
| WO-2016205648-A1 | PROCESS FOR PREPARING AN ACRYLOYLOXYSILANE | DOW CORNING CORPORATION (US) | 2016-12-22 | — | — | WO | disclosed |
| WO-2016205642-A1 | PROCESS FOR PREPARING AN ACRYLOYLOYLOXYSILANE | DOW CORNING CORPORATION (US) | 2016-12-22 | — | — | WO | disclosed |
| US-9518072-B2 | Ester-functional silanes and the preparation and use thereof; and use of iminium compounds as phase transfer catalysts | DOW CORNING CORPORATION (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150126676-A1 | Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts | DOW SILICONES CORPORATION | 2015-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150126676-A1 | Ester-Functional Silanes And The Preparation And Use Thereof; And Use Of Iminium Compounds As Phase Transfer Catalysts | ICMT, INTS9, HDHD5 | ATM 2209/4885HCAR2 2989/4885MAPT 2152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.